This Small Cap Stock Surged Over 100%
Key Points Shares of Elox surged almost 100% after receiving an increased price target from Oppenheimer and published preclinical data demonstrating activity against subtypes of colorectal cancer.Oppenheimer raised Eloxx’s price target from $50 to $55, implying a potential upside of nearly 500%.The stock has a micro float and low trading volume, resulting in a significant historical range and volatility in its stock price.5 stocks we like better than Eloxx PharmaceuticalsArguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals (...